Pacific Biosciences Of California Operating Margin 2012-2025 | PACB
Current and historical operating margin for Pacific Biosciences Of California (PACB) over the last 10 years. The current operating profit margin for Pacific Biosciences Of California as of September 30, 2025 is -114.21%.
| Pacific Biosciences Of California Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $0.15B | $-0.67B | -432.47% |
| 2025-06-30 | $0.16B | $-0.69B | -442.95% |
| 2025-03-31 | $0.15B | $-0.82B | -540.79% |
| 2024-12-31 | $0.15B | $-0.47B | -307.79% |
| 2024-09-30 | $0.17B | $-0.41B | -236.42% |
| 2024-06-30 | $0.19B | $-0.43B | -225.93% |
| 2024-03-31 | $0.20B | $-0.32B | -161.19% |
| 2023-12-31 | $0.20B | $-0.33B | -166.17% |
| 2023-09-30 | $0.17B | $-0.33B | -195.88% |
| 2023-06-30 | $0.15B | $-0.33B | -223.29% |
| 2023-03-31 | $0.13B | $-0.32B | -241.35% |
| 2022-12-31 | $0.13B | $-0.31B | -242.52% |
| 2022-09-30 | $0.14B | $-0.29B | -210.29% |
| 2022-06-30 | $0.14B | $-0.29B | -205.04% |
| 2022-03-31 | $0.14B | $-0.26B | -188.89% |
| 2021-12-31 | $0.13B | $-0.21B | -161.07% |
| 2021-09-30 | $0.12B | $-0.17B | -139.34% |
| 2021-06-30 | $0.11B | $-0.12B | -113.21% |
| 2021-03-31 | $0.09B | $-0.11B | -115.22% |
| 2020-12-31 | $0.08B | $-0.11B | -132.91% |
| 2020-09-30 | $0.08B | $-0.10B | -123.75% |
| 2020-06-30 | $0.08B | $-0.10B | -124.10% |
| 2020-03-31 | $0.09B | $-0.10B | -113.19% |
| 2019-12-31 | $0.09B | $-0.10B | -109.89% |
| 2019-09-30 | $0.08B | $-0.11B | -136.14% |
| 2019-06-30 | $0.08B | $-0.11B | -139.24% |
| 2019-03-31 | $0.08B | $-0.11B | -142.11% |
| 2018-12-31 | $0.08B | $-0.10B | -129.11% |
| 2018-09-30 | $0.08B | $-0.09B | -109.52% |
| 2018-06-30 | $0.09B | $-0.09B | -98.89% |
| 2018-03-31 | $0.09B | $-0.09B | -103.41% |
| 2017-12-31 | $0.09B | $-0.09B | -95.74% |
| 2017-09-30 | $0.10B | $-0.09B | -91.58% |
| 2017-06-30 | $0.10B | $-0.08B | -85.42% |
| 2017-03-31 | $0.10B | $-0.08B | -78.35% |
| 2016-12-31 | $0.09B | $-0.07B | -79.12% |
| 2016-09-30 | $0.10B | $-0.06B | -54.46% |
| 2016-06-30 | $0.09B | $-0.04B | -38.89% |
| 2016-03-31 | $0.09B | $-0.03B | -29.79% |
| 2015-12-31 | $0.09B | $-0.03B | -30.11% |
| 2015-09-30 | $0.07B | $-0.05B | -60.81% |
| 2015-06-30 | $0.08B | $-0.06B | -69.14% |
| 2015-03-31 | $0.07B | $-0.06B | -94.03% |
| 2014-12-31 | $0.06B | $-0.06B | -101.64% |
| 2014-09-30 | $0.05B | $-0.06B | -115.09% |
| 2014-06-30 | $0.04B | $-0.07B | -187.18% |
| 2014-03-31 | $0.03B | $-0.08B | -220.59% |
| 2013-12-31 | $0.03B | $-0.08B | -278.57% |
| 2013-09-30 | $0.03B | $-0.08B | -332.00% |
| 2013-06-30 | $0.02B | $-0.09B | -409.52% |
| 2013-03-31 | $0.02B | $-0.09B | -404.55% |
| 2012-12-31 | $0.03B | $-0.10B | -369.23% |
| 2012-09-30 | $0.03B | $-0.10B | -303.13% |
| 2012-06-30 | $0.04B | $-0.10B | -257.50% |
| 2012-03-31 | $0.04B | $-0.10B | -234.09% |
| 2011-12-31 | $0.03B | $-0.11B | -323.53% |
| 2011-09-30 | $0.02B | $-0.12B | -563.64% |
| 2011-06-30 | $0.01B | $-0.14B | -1236.36% |
| 2011-03-31 | $0.00B | $-0.15B | -14600.00% |
| 2010-12-31 | $0.00B | $-0.14B | -7050.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.518B | $0.154B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.769B | 23.72 |
| Intuitive Surgical (ISRG) | United States | $169.156B | 65.25 |
| IDEXX Laboratories (IDXX) | United States | $51.392B | 49.24 |
| Edwards Lifesciences (EW) | United States | $45.321B | 30.39 |
| Alcon (ALC) | Switzerland | $38.763B | 26.12 |
| IQVIA Holdings (IQV) | United States | $30.817B | 16.65 |
| Mettler-Toledo (MTD) | United States | $28.249B | 32.32 |
| DexCom (DXCM) | United States | $27.258B | 37.58 |
| STERIS (STE) | Ireland | $23.929B | 24.19 |
| Waters (WAT) | United States | $22.443B | 29.68 |
| Coloplast (CLPBY) | Denmark | $18.886B | 32.23 |
| Hologic (HOLX) | United States | $16.676B | 17.45 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.939B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.116B | 11.71 |
| Penumbra (PEN) | United States | $13.394B | 94.22 |
| Globus Medical (GMED) | United States | $11.711B | 24.58 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.269B | 23.29 |
| Glaukos (GKOS) | United States | $6.520B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.967B | 18.96 |
| Teleflex (TFX) | United States | $4.680B | 7.46 |
| TransMedics (TMDX) | United States | $4.429B | 52.47 |
| LivaNova (LIVN) | United Kingdom | $3.551B | 19.18 |
| Integer Holdings (ITGR) | United States | $2.986B | 14.02 |
| Veracyte (VCYT) | United States | $2.756B | 31.41 |
| Elekta AB (EKTAY) | Sweden | $2.223B | 20.79 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 22.64 |
| Alphatec Holdings (ATEC) | United States | $2.005B | 0.00 |
| UFP Technologies (UFPT) | United States | $1.976B | 26.09 |
| Artivion (AORT) | United States | $1.869B | 85.78 |
| AxoGen (AXGN) | United States | $1.564B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.531B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.284B | 0.00 |
| IRadimed (IRMD) | United States | $1.203B | 57.30 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.928B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.847B | 4.59 |
| SiBone (SIBN) | United States | $0.682B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.643B | 12.82 |
| Tactile Systems Technology (TCMD) | United States | $0.608B | 35.34 |
| Beta Bionics (BBNX) | United States | $0.583B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.582B | 0.00 |
| NeuroPace (NPCE) | United States | $0.516B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.504B | 13.12 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.503B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.416B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.322B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.316B | 52.59 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.158B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.150B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.116B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.109B | 0.00 |
| Hyperfine (HYPR) | United States | $0.101B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Accuray (ARAY) | United States | $0.068B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.059B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.046B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.046B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.016B | 0.00 |
| Envoy Medical (COCH) | United States | $0.015B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |